Get started
Author

Manuela Tosi

High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults
2017 · Kathryn G. Roberts, Zhaohui Gu, et al. · Journal of Clinical Oncology · 453
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
2009 · Renato Bassan, Orietta Spinelli, et al. · Blood · 426
PDF
Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00
2010 · Renato Bassan, Giuseppe Rossi, et al. · Journal of Clinical Oncology · 272
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
2016 · Federico Lussana, Tamara Intermesoli, et al. · Transplantation and Cellular Therapy · 88
PDF
Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study
2025 · Renato Bassan, Sabina Chiaretti, et al. · Blood · 47
PDF
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
2020 · Renato Bassan, Chiara Pavoni, et al. · Blood Cancer Journal · 46
PDF
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia
2017 · Renato Bassan, Tamara Intermesoli, et al. · Clinical Lymphoma Myeloma & Leukemia · 22
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)
2016 · Renato Bassan, Arianna Masciulli, et al. · Blood · 22
Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes
2020 · Roberta Cavagna, Marie L. Guinea Montalvo, et al. · Cancers · 13
PDF
Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-negative Adult Acute Lymphoblastic Leukemia
2014 · Orietta Spinelli, Manuela Tosi, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 13
PDF
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia
2022 · Irene Della Starza, Lucia A. De Novi, et al. · Journal of Molecular Diagnostics · 12
PDF
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
2021 · Manuela Tosi, Orietta Spinelli, et al. · Cancers · 10
PDF
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
2022 · Giuliana Rizzuto, Matteo Leoncin, et al. · Clinical Case Reports · 8
PDF
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases
2022 · Roberta Soscia, Irene Della Starza, et al. · Hematological Oncology · 5
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations
2020 · Silvia Salmoiraghi, Roberta Cavagna, et al. · Genes · 4
PDF
Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality
2018 · Paul Maciocia, Margarida Neves, et al. · Blood · 2
Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte®) In Adult Acute Lymphoblastic Leukemia (ALL)
2013 · Renato Bassan, Arianna Masciulli, et al. · Blood · 2
In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome
2012 · Tamara Intermesoli, Chiara Cattaneo, et al. · Blood · 2
Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group
2010 · Alessandro Rambaldi, Orietta Spinelli, et al. · Blood · 2
Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07
2010 · Renato Bassan, Tamara Intermesoli, et al. · Blood · 2
Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing
2023 · Jacob F. Hess, Michaela Kotrová, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 1
Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).
2012 · Renato Bassan, Orietta Spinelli, et al. · Blood · 1
In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.
2012 · Renato Bassan, Orietta Spinelli, et al. · Blood · 1
Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL).
2005 · Renato Bassan, Orietta Spinelli, et al. · Blood · 1
Integrated Mrd Assessment by Ddpcr and Ngs in Adult Acute Lymphoblastic Leukemia
2026 · Giuliana Rizzuto, Manuela Tosi, et al. · Research Square
Works count: 35
Citation count: 1,455
H-index: 11
I10-index: 12
Year
Topic
Type